Recruiting studies: Resectable Colon Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05185245 MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NA · 1 location(s) · Sun Yat-sen University · NCT06204484 Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144 In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
Phase 1 · 1 location(s) · University Health Network, Toronto · NCT05611034 Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cance
NA · 13 location(s) · City of Hope Medical Center · NCT07125729 Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05194878 A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
Phase 3 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06686576 Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Can
Phase 2 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06830239 Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research
NA · 1 location(s) · Hospital Vall d'Hebron · NCT05398380 Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT05797077 Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or W
Phase 2 · 1 location(s) · Zhejiang University · NCT07581912 CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035 An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cance
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT04796818 Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
EARLY_Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT02172651 LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis
NA · 1 location(s) · Azienda Ospedaliero-Universitaria di Modena · NCT05186116 Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Phase 2 · 1 location(s) · Baylor College of Medicine · NCT05870800 Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Tre
Phase 2 · 1 location(s) · Spanish Cooperative Group for the Treatment of Digestive Tum · NCT06207656 Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Phase 3 · 1 location(s) · Akeso · NCT07412613 Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
Phase 2 · 1 location(s) · Gruppo Oncologico del Nord-Ovest · NCT05845450 Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.
Phase 2 · 1 location(s) · University of Saskatchewan · NCT03401294 Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
Phase 2 · 11 location(s) · City of Hope Medical Center · NCT07595874 Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
NA · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT06731998 Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Phase N/A · 3 location(s) · Mayo Clinic · NCT06349642 Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Phase 3 · 266 location(s) · GlaxoSmithKline · NCT05855200 Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Phase 1/Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT03965234 Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer
Phase 3 · 1 location(s) · Fudan University · NCT03125980 Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases
NA · 1 location(s) · University Health Network, Toronto · NCT02864485 Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Phase 2/Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06280495

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.